To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disease activity in patients with immune-mediated diseases
Vaccination is the most effective method of controlling seasonal influenza infections and preventing...
BACKGROUND: The pandemic by the novel H1N1 virus has created the need to study any probable effects ...
The 2009 pandemic A/H1N1 influenza outbreak represented a theoretical risk for patients with autoimm...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 deaths world...
BACKGROUND: The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 ...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
Despite long-term investment, influenza continues to be a significant worldwide problem. The corners...
The emergence of a new influenza A virus (H1N1) variant in 2009 led to a worldwide vaccination progr...
To identify the determinants of antibody responses to adjuvanted influenza A/H1N1/09 vaccines in a c...
After the influenza H1N1 pandemic of 2009, the seasonal A/Brisbane/59/2007 strain was replaced by th...
Influenza virus hemagglutinin (HA) surface glycoprotein is currently the primary target of licensed ...
An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogeni...
In spite of there being a number of vaccines, influenza remains a significant global cause of morbid...
Vaccination is the most effective method of controlling seasonal influenza infections and preventing...
BACKGROUND: The pandemic by the novel H1N1 virus has created the need to study any probable effects ...
The 2009 pandemic A/H1N1 influenza outbreak represented a theoretical risk for patients with autoimm...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 deaths world...
BACKGROUND: The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 ...
Objectives. To assess the 2009 influenza vaccine A/H1N1 on antibody response, side effects and disea...
Despite long-term investment, influenza continues to be a significant worldwide problem. The corners...
The emergence of a new influenza A virus (H1N1) variant in 2009 led to a worldwide vaccination progr...
To identify the determinants of antibody responses to adjuvanted influenza A/H1N1/09 vaccines in a c...
After the influenza H1N1 pandemic of 2009, the seasonal A/Brisbane/59/2007 strain was replaced by th...
Influenza virus hemagglutinin (HA) surface glycoprotein is currently the primary target of licensed ...
An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogeni...
In spite of there being a number of vaccines, influenza remains a significant global cause of morbid...
Vaccination is the most effective method of controlling seasonal influenza infections and preventing...
BACKGROUND: The pandemic by the novel H1N1 virus has created the need to study any probable effects ...
The 2009 pandemic A/H1N1 influenza outbreak represented a theoretical risk for patients with autoimm...
DOI
Add to ORKG